The Early Perioperative Outcomes of Subxiphoid Approach Versus Lateral Intercostal Approach Thoracoscopic Thymectomy for Thymic Tumors: A Meta-Analysis

Abstract

Objectives:

To systematically evaluate the early perioperative outcomes regarding the safety and efficacy of subxiphoid thoracoscopic thymectomy (STT) versus lateral intercostal thoracoscopic thymectomy (LITT) for patients with thymic tumors.

Methods:

A thorough literature search of the following online databases was performed: Web of Science, PubMed, Embase, Cochrane Library, Google Scholar, and ClinicalTrials.gov. Original research articles published before December 30, 2020, that compared STT with LITT were included. Meta-analysis was performed for early perioperative outcomes, including blood loss, pain score, duration of hospital stay, operative time, chest tube drainage time, and incidence of postoperative complications.

Results:

Six studies that included 604 patients were finally selected for our analysis, with 296 cases of STT and 308 cases of LITT. Our results showed that compared with LITT, STT was associated with less blood loss (standardized mean difference = −0.81, 95% confidence interval [CI] = −1.49 to −0.14, P = .02), a lower pain score (weighted mean difference [WMD] = −2.55, 95% CI = −3.52 to −1.59; P < .00001), and a shorter hospital stay (WMD = −1.37, 95% CI = −2.37 to −0.36; P = .008), whereas there were no significant differences with regard to the operative time (WMD = −10.04, 95% CI = −22.29 to 2.21, P = .11), chest tube drainage time (WMD = −0.58, 95% CI = −1.17 to 0.02, P = .06), and the incidence of postoperative complications (odds ratio = 0.75, 95% CI = 0.39 to 1.44, P = .38).

Conclusions:

The current analysis suggests that STT is superior to LITT with respect to the early perioperative outcomes, and STT is a safe and effective surgical method for patients with thymic tumors.